1999
DOI: 10.1007/s005400050033
|View full text |Cite
|
Sign up to set email alerts
|

Does adenosine release taurine in the A1-receptor-rich hippocampus?

Abstract: Adenosine delivered by microdialysis into the interstitial fluid of nonischemic rabbit hippocampus induces release of taurine in a dose-dependent manner, suggesting involvement of additional mechanisms besides the already known A2-receptor-induced release. Taurine can be anticipated to have protective effects in the hippocampus as well.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

1999
1999
2017
2017

Publication Types

Select...
4
4
1

Relationship

1
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…In the vitreous fluid of diabetic patients, the levels of interleukin-1 beta (IL-1 β ), IL-6, and tumor necrosis factor (TNF) are increased [810]. In addition, an increase in the production of cytokines, such as IL-1 β and TNF, expression of adhesion molecules, leukocyte adhesion, and vascular permeability [1113] have been observed in the retina of diabetic animals. Moreover, in the retinas of streptozotocin-induced diabetic rats, the levels of IL-1 β are also increased [1417], and this was correlated with an increase in BRB permeability [12, 14].…”
Section: Introductionmentioning
confidence: 99%
“…In the vitreous fluid of diabetic patients, the levels of interleukin-1 beta (IL-1 β ), IL-6, and tumor necrosis factor (TNF) are increased [810]. In addition, an increase in the production of cytokines, such as IL-1 β and TNF, expression of adhesion molecules, leukocyte adhesion, and vascular permeability [1113] have been observed in the retina of diabetic animals. Moreover, in the retinas of streptozotocin-induced diabetic rats, the levels of IL-1 β are also increased [1417], and this was correlated with an increase in BRB permeability [12, 14].…”
Section: Introductionmentioning
confidence: 99%
“…[5][6][7] Taurine is released by adenosine in all areas of the brain in in vivo animals, 8 including areas with predominantly A1 receptors, such as the hippocampus, in a dose-dependent manner. 9 Although we have not proven that taurine is released in the spinal cord as well, there are no reasons to believe that it would not be.…”
Section: Alternate Explanation Of the Additive Protective Effects Of Regional Infusion Of Hypothermic Saline And Adenosine Solutionsmentioning
confidence: 88%
“…Adenosine is a very short-acting substance released from the ischemia induced degradation product of ATP. During ischemia, adenosine activates the A1 receptor on the cell membrane initiating a series of intracellular events including activation of G-proteins, phospholipase C, protein kinase C, and ATP-sensitive potassium channels, and release of neurotransmitters [13,14,15]. The specific roles that adenosine, ATP sensitive potassium channels, or other agents may play in models of acute preconditioning remain unknown.…”
Section: Discussionmentioning
confidence: 99%